Boothwyn Pharmacy LLC recalls Semaglutide, 2.5 mg/mL injection, 2 mL., Boothwyn Pharmacy
- Recall date
- July 9, 2025
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-0606-2025
- FDA classification
- Class II
- Brand / firm
- Boothwyn Pharmacy LLC
- Sold / distributed
- U.S. Nationwide
Why it was recalled
Subpotent Drug
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Semaglutide, 2.5 mg/mL injection, 2 mL., Boothwyn Pharmacy
Get recall alerts
Free email alert whenever Boothwyn Pharmacy LLC has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Boothwyn Pharmacy LLC